Plant Composition for HIV and Hepatitis C Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for viral blood diseases such as HIV and hepatitis C have long incubation periods leading to unnoticed transmission, lack of effective prevention, and significant side effects from existing therapies, which are not only undesirable but also potentially fatal.
Innovation Solution
A plant-based composition comprising sulfur flower, tannin-rich plants like Agrimony (GAFT) or Gambier, and Nigella oil, combined with a pharmaceutically acceptable support like honey, which reduces viral load and increases CD4 subpopulation T lymphocytes without side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional retroviral therapies are used to treat HIV, then viral load is reduced, but side effects and toxicity increase significantly
Solution Approach 1:
The patent employs natural plant-based compounds with short half-lives that are metabolized and eliminated from the body without accumulation. These transient compounds provide therapeutic effect during their active period and then naturally degrade, avoiding the long-term toxicity and persistence issues associated with conventional retroviral drugs that remain in the system for extended periods causing cumulative side effects
Solution Approach 2:
The invention combines multiple plant-derived compounds (tannins, catechins, flavonoids) with sulfur flowers in a composite formulation. This synergistic combination enhances antiviral efficacy while the natural diversity of components reduces toxicity compared to single synthetic compounds, as the body can process and eliminate different natural compounds through various metabolic pathways
2Object-affected harmful factors
If early treatment is delayed due to long incubation period, then symptoms are avoided, but virus transmission increases
Solution Approach 1:
The patent enables preliminary antiviral action by detecting and treating the virus during the asymptomatic incubation period. The plant-based composition can be administered early in infection when viral load is lower, preventing progression to symptomatic disease while simultaneously reducing viral replication and transmission risk during the otherwise dangerous window of unknowing contagion
3Reliability
If conventional treatments are administered, then some therapeutic effect is achieved, but fatal side effects occur
Solution Approach 1:
The patent utilizes sulfur flowers, a substance that in conventional medicine requires careful dosing to avoid toxicity, but in this plant-based formulation works synergistically with tannins and catechins to enhance antiviral activity while the natural compounds guide safe metabolism and elimination. The formulation converts potentially harmful concentrated sulfur into a beneficial therapeutic component when combined with specific plant extracts
Data Source
Figure 1
Figure 2
AI summary
The invention relates to a plant composition for the treatment or prevention of viral blood-borne diseases such as the diseases caused by the human immunodeficiency virus (HIV) or hepatitis C. According to the invention, the composition mainly includes flower of sulphur, a plant which contains catechins and a tannin agent, as well as a pharmaceutically acceptable medium. The invention also relates to the method for manufacturing said composition. The invention can be used in the field of treating or preventing viral blood-borne diseases such as the diseases caused by the human immunodeficiency virus (HIV) or hepatitis C.